Suppr超能文献

健康与疾病状态下肾脏中的嘌呤能信号传导

Purinergic signalling in the kidney in health and disease.

作者信息

Burnstock Geoffrey, Evans Louise C, Bailey Matthew A

机构信息

Autonomic Neuroscience Centre, University College Medical School, Rowland Hill Street, London, NW3 2PF, UK,

出版信息

Purinergic Signal. 2014 Mar;10(1):71-101. doi: 10.1007/s11302-013-9400-5. Epub 2013 Nov 22.

Abstract

The involvement of purinergic signalling in kidney physiology and pathophysiology is rapidly gaining recognition and this is a comprehensive review of early and recent publications in the field. Purinergic signalling involvement is described in several important intrarenal regulatory mechanisms, including tuboglomerular feedback, the autoregulatory response of the glomerular and extraglomerular microcirculation and the control of renin release. Furthermore, purinergic signalling influences water and electrolyte transport in all segments of the renal tubule. Reports about purine- and pyrimidine-mediated actions in diseases of the kidney, including polycystic kidney disease, nephritis, diabetes, hypertension and nephrotoxicant injury are covered and possible purinergic therapeutic strategies discussed.

摘要

嘌呤能信号传导在肾脏生理和病理生理中的作用正迅速得到认可,本文全面综述了该领域的早期和近期出版物。嘌呤能信号传导参与了几种重要的肾内调节机制,包括球管反馈、肾小球和球外微循环的自动调节反应以及肾素释放的控制。此外,嘌呤能信号传导影响肾小管各节段的水和电解质转运。本文涵盖了关于嘌呤和嘧啶介导的肾脏疾病作用的报告,包括多囊肾病、肾炎、糖尿病、高血压和肾毒物损伤,并讨论了可能的嘌呤能治疗策略。

相似文献

1
Purinergic signalling in the kidney in health and disease.
Purinergic Signal. 2014 Mar;10(1):71-101. doi: 10.1007/s11302-013-9400-5. Epub 2013 Nov 22.
2
Purinergic signalling in the kidney: In physiology and disease.
Biochem Pharmacol. 2021 May;187:114389. doi: 10.1016/j.bcp.2020.114389. Epub 2020 Dec 31.
3
Unresolved issues and controversies in purinergic signalling.
J Physiol. 2008 Jul 15;586(14):3307-12. doi: 10.1113/jphysiol.2008.155903. Epub 2008 May 22.
4
Purinergic signalling in the liver in health and disease.
Purinergic Signal. 2014 Mar;10(1):51-70. doi: 10.1007/s11302-013-9398-8. Epub 2013 Nov 24.
5
Purinergic signalling: pathophysiology and therapeutic potential.
Keio J Med. 2013;62(3):63-73. doi: 10.2302/kjm.2013-0003-re.
6
Purinergic signalling in neuron-glia interactions.
Nat Rev Neurosci. 2006 Jun;7(6):423-36. doi: 10.1038/nrn1928.
7
Purinergic signalling in the gastrointestinal tract and related organs in health and disease.
Purinergic Signal. 2014 Mar;10(1):3-50. doi: 10.1007/s11302-013-9397-9. Epub 2013 Dec 4.
8
Purinergic signalling: past, present and future.
Braz J Med Biol Res. 2009 Jan;42(1):3-8. doi: 10.1590/s0100-879x2008005000037. Epub 2008 Oct 3.
9
Intrarenal purinergic signaling in the control of renal tubular transport.
Annu Rev Physiol. 2010;72:377-93. doi: 10.1146/annurev-physiol-021909-135825.
10
Purinergic signalling in the urinary tract in health and disease.
Purinergic Signal. 2014 Mar;10(1):103-55. doi: 10.1007/s11302-013-9395-y. Epub 2013 Nov 22.

引用本文的文献

1
Mitochondrial Dysfunction: The Silent Catalyst of Kidney Disease Progression.
Cells. 2025 May 28;14(11):794. doi: 10.3390/cells14110794.
2
P2 receptors signaling in the esophagus: from inflammation to cancer.
Purinergic Signal. 2025 May 8. doi: 10.1007/s11302-025-10089-4.
6
Molecular insights into P2X signalling cascades in acute kidney injury.
Purinergic Signal. 2024 Oct;20(5):477-486. doi: 10.1007/s11302-024-09987-w. Epub 2024 Jan 22.
7
Revisiting the Use of Normal Saline for Peritoneal Washing in Ovarian Cancer.
Int J Mol Sci. 2023 Nov 17;24(22):16449. doi: 10.3390/ijms242216449.
9
Therapeutic potential for P2Y receptor antagonism.
Purinergic Signal. 2023 Jun;19(2):401-420. doi: 10.1007/s11302-022-09900-3. Epub 2022 Oct 11.
10
Ion channels and channelopathies in glomeruli.
Physiol Rev. 2023 Jan 1;103(1):787-854. doi: 10.1152/physrev.00013.2022. Epub 2022 Aug 25.

本文引用的文献

1
CFTR structure and function: is there a role in the kidney?
Biophys Rev. 2009 Mar;1(1):3-12. doi: 10.1007/s12551-008-0002-3. Epub 2009 Jan 17.
2
Effect of P2X4 and P2X7 receptor antagonism on the pressure diuresis relationship in rats.
Front Physiol. 2013 Oct 25;4:305. doi: 10.3389/fphys.2013.00305. eCollection 2013.
4
Adenosine effects on renal function in the rat: role of sodium intake and cytochrome P450.
Nephron Physiol. 2013;123(1-2):1-5. doi: 10.1159/000353705. Epub 2013 Jul 25.
5
Real-time electrochemical detection of ATP and H₂O₂ release in freshly isolated kidneys.
Am J Physiol Renal Physiol. 2013 Jul 1;305(1):F134-41. doi: 10.1152/ajprenal.00129.2013. Epub 2013 Apr 17.
6
Adenosine A2A receptor: a target for regulating renal interstitial fibrosis in obstructive nephropathy.
PLoS One. 2013 Apr 9;8(4):e60173. doi: 10.1371/journal.pone.0060173. Print 2013.
7
ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy.
Int J Biochem Cell Biol. 2013 May;45(5):932-43. doi: 10.1016/j.biocel.2013.02.009. Epub 2013 Feb 19.
8
ATP and arterial calcification.
Eur J Clin Invest. 2013 Apr;43(4):405-12. doi: 10.1111/eci.12055. Epub 2013 Feb 10.
9
Targeting adenosine signaling to treatment of diabetic nephropathy.
Curr Drug Targets. 2013 Apr;14(4):490-6. doi: 10.2174/1389450111314040010.
10
Functional expression of the damage-associated molecular pattern receptor P2X7 on canine kidney epithelial cells.
Vet Immunol Immunopathol. 2012 Dec 15;150(3-4):228-33. doi: 10.1016/j.vetimm.2012.09.040. Epub 2012 Oct 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验